StockData
LB Pharmaceuticals Inc logo

LB Pharmaceuticals Inc (LBRX) stock

LBRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$38.85−1.19 (-2.97%)

Close on Nov 20, 2026Market cap $1.25BP/E –Yield –

LB Pharmaceuticals gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for LB Pharmaceuticals

LB Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More LB Pharmaceuticals figures

See a number that looks wrong?